1. Home
  2. UK vs VBIO Comparison

UK vs VBIO Comparison

Compare UK & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ucommune International Ltd

UK

Ucommune International Ltd

N/A

Current Price

$1.95

Market Cap

1.4M

ML Signal

N/A

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$2.54

Market Cap

1.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UK
VBIO
Founded
2015
2016
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
UK
VBIO
Price
$1.95
$2.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.2K
★ 681.5K
Earning Date
10-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $780,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.24
$0.11
52 Week High
$5.90
$4.39

Technical Indicators

Market Signals
Indicator
UK
VBIO
Relative Strength Index (RSI) N/A 52.64
Support Level N/A $2.05
Resistance Level N/A $4.14
Average True Range (ATR) 0.00 0.50
MACD 0.00 0.01
Stochastic Oscillator 0.00 26.07

Price Performance

Historical Comparison
UK
VBIO

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has two operating segments: Workspace membership, and Other services. The Workspace membership segment generates the majority of the company's revenue.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: